Factor VIII light chain mutations and cysteine substitutions predispose for inhibitor development in mild and moderate haemophilia A: first results from the INSIGHT study
Author(s):
Eckhardt, C.L.; Peters, M.; Kamphuisen, W.P.; Astermark, J.; Oldenburg, J.; Hay, C.R.M.; Santagostino, E.; Ingerslev, J.; D'Oiron, R.; Bom, J.G. van der (0000-0001-5251-0342); Fijnvandraat, K.; Insight Investigators
